Verastem (VSTM) Change in Acquisitions & Divestments (2012 - 2024)
Verastem's (VSTM) quarterly Change in Acquisitions & Divestments came in at $29.0 million in Q2 2024, up 107.14% year-on-year from $14.0 million in Q3 2023, and down 6.45% quarter-over-quarter from $31.0 million in Q1 2024.
Verastem (VSTM) Change in Acquisitions & Divestments (2012 - 2024) Analysis & Trends
Verastem's Change in Acquisitions & Divestments history runs 13 years deep, the most recent figure standing at $29.0 million for Q2 2024.
- On a quarterly basis, Change in Acquisitions & Divestments rose 107.14% year-over-year to $29.0 million in Q2 2024; TTM through Dec 2024 was $60.0 million, a 15.38% increase from a year earlier, with the FY2024 full-year figure at $60.0 million, up 15.38% from the prior year.
- Change in Acquisitions & Divestments eased to $29.0 million in Q2 2024 per VSTM's latest filing, from $31.0 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $38.1 million in Q2 2021 and bottomed at $5.4 million in Q1 2021.
- The 5-year median for Change in Acquisitions & Divestments is $24.6 million (2022), against an average of $22.5 million.
- Across the five-year window, Change in Acquisitions & Divestments slumped 83.23% in 2021 and soared 351.16% in 2022, its largest moves.
- Year by year, Change in Acquisitions & Divestments stood at $32.0 million in 2020, then advanced by 3.74% to $33.2 million in 2021, then slumped by 53.38% to $15.5 million in 2022, then jumped by 61.29% to $25.0 million in 2023, then advanced by 16.0% to $29.0 million in 2024.
- Per Business Quant, the three latest VSTM Change in Acquisitions & Divestments figures stand at $29.0 million (Q2 2024), $31.0 million (Q1 2024), and $25.0 million (Q4 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,538.84 Bn | 65,538.56 Bn | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 4 | BeOne Medicines | 469.46 Bn | 464.67 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.69 Bn | 115.45 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.41 Bn | 61.65 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.84 Bn | 62.84 Bn | - |
| 8 | Argenx Se | 56.10 Bn | 50.91 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.48 Bn | 34.47 Bn | 959.66 Mn |
| 10 | Verastem | 623.17 Mn | 425.34 Mn | 15.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 29.00 Mn |
| Jun 30, 2024 | 29.00 Mn |
| Mar 31, 2024 | 31.00 Mn |
| Mar 31, 2024 | 31.00 Mn |
| Dec 31, 2023 | 25.00 Mn |
| Dec 31, 2023 | 25.00 Mn |
| Jun 30, 2023 | 14.00 Mn |
| Jun 30, 2023 | 14.00 Mn |
| Mar 31, 2023 | 13.00 Mn |
| Mar 31, 2023 | 13.00 Mn |
| Dec 31, 2022 | 15.50 Mn |
| Dec 31, 2022 | 15.50 Mn |
| Sep 30, 2022 | 15.00 Mn |
| Sep 30, 2022 | 15.00 Mn |
| Jun 30, 2022 | 29.25 Mn |
| Jun 30, 2022 | 29.25 Mn |
| Mar 31, 2022 | 24.25 Mn |
| Mar 31, 2022 | 24.25 Mn |
| Dec 31, 2021 | 33.25 Mn |
| Dec 31, 2021 | 33.25 Mn |